0.23Open0.30Pre Close5 Volume230 Open Interest4.00Strike Price103.00Turnover107.13%IV19.83%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry0.20Extrinsic Value100Contract SizeAmericanOptions Type-0.2248Delta0.2250Gamma23.70Leverage Ratio-0.0078Theta-0.0008Rho-5.33Eff Leverage0.0037Vega
CorMedix Stock Discussion
Dow Jones· 4 mins ago. CorMedix: DefenCath Catheter Lock Solution Is FDA Approved to Reduce Incidence of Catheter-Related Bloodstream Infections in Adult Patients With Kidney Failure >CRMD
Dow Jones· 2 mins ago
Benzinga· just
CorMedix Receives FDA Approval For Defencath - moomoo
No comment yet